MEG and EEG Alpha Activity Detection for Mild Traumatic Brain Injury
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional brain imaging methods are ineffective in detecting mild traumatic brain injury (mTBI), and current clinical approaches lack objective diagnostics to identify pathophysiologic brain changes associated with youth concussions, leading to unsatisfactory diagnosis and treatment.
Innovation Solution
Utilizing magnetoencephalography (MEG) and electroencephalography (EEG) to measure brain activity, particularly alpha, delta, theta, and beta frequencies in source space, to objectively diagnose and monitor mTBI, especially in adolescents, by establishing normative databases for individual-level analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional brain imaging methods (MRI and CT) are used to detect mTBI, then the structural damage can be visualized, but the detection sensitivity is low with intracranial lesions observed in only 4-28% of cases
Solution Approach 1:
The patent replaces traditional structural imaging methods (MRI, CT) with functional imaging methods (fMRI, PET, SPECT) that measure metabolic and hemodynamic changes. This substitution enables detection of functional abnormalities in mTBI patients even when structural damage is absent, significantly improving detection sensitivity from 4-28% to much higher rates by capturing physiological changes rather than just anatomical structures.
Solution Approach 2:
The patent shifts the measurement parameters from structural anatomy (presence of intracranial lesions) to functional parameters (cerebral blood flow, metabolic activity, oxygen extraction). By changing what is being measured from static structure to dynamic function, the method can detect subtle mTBI pathophysiology that structural imaging misses, thereby improving both sensitivity and diagnostic accuracy.
2Measurement precision
If standard diffusion tensor imaging (DTI) is used to detect traumatic axonal injury, then white-matter injury can be visualized, but the method fails to detect mTBI at the individual patient level in the acute phase
Solution Approach 1:
The patent employs multiple functional imaging modalities (fMRI, PET, SPECT) that can detect metabolic and hemodynamic changes immediately after injury, before structural changes become apparent on DTI or other structural imaging. This preliminary detection capability allows for immediate diagnosis and intervention in the acute phase, eliminating the time loss associated with waiting for structural changes to manifest.
Solution Approach 2:
The patent integrates multiple functional imaging techniques that can detect various aspects of mTBI pathophysiology (blood flow, metabolism, oxygen extraction) simultaneously. This multi-functional approach increases the probability of detecting individual patient abnormalities at the acute phase by capturing different physiological dimensions, thereby improving individual-level detection sensitivity without time loss.
3Adaptability or versatility
If conventional neuroimaging is used for mTBI diagnosis, then the imaging protocols are standardized and widely available, but the methods lack the sensitivity to identify pathophysiologic brain changes in most mTBI cases
Solution Approach 1:
The patent combines multiple functional imaging modalities (fMRI, PET, SPECT) with complementary physiological measurements to create a comprehensive diagnostic approach. By merging these different techniques that each capture different aspects of brain function, the method maintains protocol standardization while achieving superior detection of pathophysiologic changes compared to any single conventional modality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides accurate and timely diagnosis of mTBI, enabling effective treatment and tracking recovery, with MEG showing higher sensitivity than traditional neuroimaging, and allowing for the evaluation of therapeutic efficacy.
Implementation Method 1
measuring brain activity in the subject by magnetoencephalography (MEG)
Implementation Method 2
measuring brain activity in the subject by magnetoencephalography (MEG) and/or electroencephalography (EEG)
Data Source
AI summary
Methods using measuring alpha activity in the brain are provided for the detection and/or diagnosis of a mild traumatic brain injury in a subject. The methods comprise measuring an alpha activity in the brain of a subject, wherein an increase in the alpha activity in the brain of the subject compared to control subjects without a brain injury or to a baseline of the subject is indicative of the subject having the mild traumatic brain injury. The alpha activity may be measured when the subject is in a resting state. The methods may further comprise administering a therapy such as a pain or headache medication to the subject with a mild traumatic brain injury.